查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1880580

犬類疫苗市場規模、佔有率、成長及全球產業分析：依類型、應用和地區劃分的洞察與預測（2024-2032 年）

Canine Vaccines Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 167 Pages | 商品交期: 請詢問到貨日

價格

犬類疫苗市場成長推動因素

全球犬類疫苗市場持續穩定成長，主要受寵物飼養量增加、預防性獸醫保健意識提高以及政府和產業對人畜共通傳染病防控日益重視的推動。根據最新市場數據，在已開發國家和新興國家廣泛開展疫苗接種的推動下，犬類疫苗市場規模在 2024 年達到 18.7 億美元。考慮到人們持續努力維護寵物健康、疫苗平台不斷進步以及獸醫基礎設施不斷完善，預計該市場規模將在 2025 年加速增長至 19.5 億美元，並在 2032 年達到 30.4 億美元。

市場成長推動因素

推動市場成長的最主要因素是全球犬隻數量的快速成長。寵物主人越來越將狗視為家庭成員，這推動了對先進獸醫護理服務（包括常規疫苗接種）的投資增加。僅在美國，全球動物健康協會報告稱，就有大約8,500萬隻寵物狗，為疫苗的長期需求奠定了堅實的基礎。人們對犬流感、萊姆病、狂犬病和犬小病毒等傳染病的日益關注，進一步強化了及時接種疫苗的必要性。

政府措施也大大促進了市場擴張。鑑於人畜共通傳染病帶來的公共衛生風險，世界各國政府都在推廣大規模疫苗接種計畫。加大對公共衛生教育的投入、與獸醫協會的合作以及免費或補貼疫苗接種活動，都在推動疫苗接種率的提高。同時，可支配收入的增加和寵物人性化趨勢的日益增長，也推高了獸醫護理成本。

市場限制因子

儘管成長前景樂觀，但該產業仍面臨一些阻礙因素。部分寵物主人對疫苗接種的猶豫態度減緩了市場普及速度，這主要是由於擔心潛在的副作用以及缺乏對疫苗接種頻率和必要性的認識。根據全球疫苗免疫聯盟（GAVI）的數據，4%的犬和12%的貓尚未接種狂犬病疫苗，凸顯了加強宣傳和教育計畫的必要性。

另一個主要障礙是獸醫專業人員短缺。世界各地的獸醫診所仍在努力招募人，導致預約名額減少和就診量下降。根據美國獸醫協會（AVMA）的報告，2021年至2023年，客戶就診量下降了2.7%，這可能會阻礙疫苗接種率的持續提高。

市場機會

市場為新型聯合疫苗的開發提供了巨大的機會。這些配方可以用更少的劑量提供對多種疾病的保護，從而提高便利性並增強免疫反應。例如，2025年7月，禮來公司（Elanco）的下一代犬流感結合疫苗TruCan Ultra CIV H3N2/H3N8獲得了美國農業部（USDA）的批准，該疫苗採用了PureFil技術。該產品旨在最大限度地減少副作用。

人畜共通傳染病的日益普及以及人們對寵物全面照護的日益關注，也促使製藥公司開發重組疫苗和精準標靶疫苗。監管支持的加強以及對獸醫研發投入的增加，進一步拓展了該領域的創新機會。

市場趨勢

犬類疫苗產業的關鍵趨勢是向更容易給藥的疫苗劑型轉變，特別是鼻內和口服疫苗。這些給藥方式可以減輕寵物的壓力，最大限度地減少操作要求，並快速激活粘膜免疫反應。 2025年3月，碩騰（Zoetis）推出了0.5毫升的Vanguard B鼻內疫苗，可有效預防博德氏菌感染。這顯示市場正朝著更便利的疫苗接種方式轉變。

區域洞察

北美 - 市場領導者

預計2024年，北美將佔全球市場最大佔有率，達到8.4億美元，佔全球收入的44.91%。該地區受益於較高的寵物擁有率、先進的獸醫實踐以及碩騰（Zoetis）、默克（Merck & Co.）和禮來（Elanco）等主要生產商的強大影響力。由於嚴格的犬類疫苗接種指南和不斷增長的寵物醫療保健支出，美國仍然是最大的貢獻者。

歐洲

預計歐洲市場將實現顯著成長，這主要得益於人們對犬類疾病風險的認識不斷提高以及寵物擁有率的不斷上升。英國有28%的成年人養狗，是推動區域擴張的主要市場。

亞太地區

預計到2032年，亞太地區將經歷最快的成長速度。城市地區寵物擁有率的上升、新產品的推出以及諸如Biobeta與印度Betina Healthcare的合作等夥伴關係，都在支持該市場的快速發展。

拉丁美洲、中東和非洲

預計這些地區將經歷緩慢但穩定的成長，這主要得益於政府主導的狂犬病疫苗接種計劃以及人們對伴侶動物健康意識的提高。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場推動因素
  • 市場阻礙因素
  • 市場機遇
  • 市場趨勢

第四章：主要發現

  • 主要國家/地區犬類疾病概覽（2024 年）
  • 主要國家/地區監管狀況（2024 年）
  • 犬類疾病疫苗接種概覽
  • 主要公司新技術應用
  • 主要產業趨勢（併購、合作等）

第五章：全球犬類疫苗市場分析、洞察與預測 (2019-2032)

  • 市場分析、洞察與預測 - 依技術分類
    • 滅活​​疫苗
    • 減毒活疫苗
    • 重組疫苗
    • 其他
  • 市場分析、洞察與預測 - 依疾病類型分類
    • 犬流感
    • 萊姆病
    • 狂犬病
    • 鉤端螺旋體病
    • 其他
  • 市場分析、洞察與預測 - 依給藥途徑分類
    • 口服
    • 注射
    • 鼻腔給藥
  • 市場分析、洞察與預測 - 依銷售管道分類
    • 獸醫院
    • 獸藥診所
    • 藥局和藥局
    • 其他
  • 市場分析、洞察與預測 - 依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章：北美犬類疫苗市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 美國
    • 加拿大

第七章：歐洲犬類疫苗市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 德國
    • 美國王國
    • 法國
    • 義大利
    • 西班牙
    • 斯堪的納維亞
    • 歐洲其他地區

第八章 亞太地區犬類疫苗市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 中國
    • 日本
    • 印度
    • 澳大利亞
    • 東南亞
    • 亞太其他地區

第九章 拉丁美洲犬類疫苗市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區

章節10：中東和非洲犬類疫苗市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 海灣合作委員會 (GCC)
    • 南非
    • 中東和非洲其他地區

第11章 競爭分析

  • 全球市佔率分析（2024）
  • 公司簡介
  • Elanco
  • Boehringer Ingelheim International GmbH
  • Virbac
  • Merck &Co., Inc.
  • Zoetis Services LLC
  • Ceva
  • Bioveta, a.s.
  • Indian Immunologicals Ltd.
  • HIPRA
  • Brilliant Bio Pharma(India)
Product Code: FBI113897

Growth Factors of canine vaccines Market

The global canine vaccines market continues its steady expansion, driven by rising pet ownership, growing awareness of preventive veterinary care, and increasing government and industry focus on combating zoonotic diseases. According to the latest market data, the canine vaccines market size reached USD 1.87 billion in 2024, supported by strong vaccination adoption across developed and emerging economies. The market is projected to rise to USD 1.95 billion in 2025 and further accelerate to USD 3.04 billion by 2032, reflecting the sustained commitment to pet health, advancements in vaccine platforms, and expansion of veterinary infrastructure.

Market Growth Drivers

The most influential driver of market growth is the rapid rise in global dog ownership. Pet parents increasingly view dogs as family members, leading to growing investments in advanced veterinary services, including routine and preventive vaccinations. In the U.S. alone, the Global Animal Health Association reported around 85 million pet dogs, presenting a strong foundation for long-term vaccine demand. Growing concerns about infectious diseases such as canine influenza, Lyme disease, rabies, and parvovirus further strengthen the necessity for timely immunization.

Government initiatives also contribute substantially to market expansion. With zoonotic diseases posing public health risks, authorities across the world are promoting mass vaccination programs. Increased investment in public health education, partnerships with veterinary associations, and free or subsidized vaccination campaigns encourage higher adoption rates. Simultaneously, rising disposable income and the broader pet humanization trend support increased veterinary expenditures.

Market Restraints

Despite positive growth prospects, the industry faces a few restraints. Vaccine hesitancy among a segment of pet owners slows market adoption, primarily due to concerns about potential side effects or lack of awareness about the frequency and necessity of vaccinations. According to GAVI, 4% of dogs and 12% of cats remain unvaccinated against rabies, highlighting the need for enhanced outreach and educational programs.

Another significant barrier is the shortage of veterinary professionals. Veterinary practices worldwide continue to experience limited staff availability, resulting in reduced appointment capacity and a decline in clinic visits. Between 2021 and 2023, the American Veterinary Medical Association reported a 2.7% decline in client visits, which may hinder consistent immunization compliance.

Market Opportunities

The market is witnessing strong opportunities in the development of novel combination vaccines. These formulations provide multi-disease protection with fewer doses, improving convenience and enhancing immune response. For example, Elanco received USDA approval in July 2025 for TruCan Ultra CIV H3N2/H3N8, a next-generation canine influenza combination vaccine using PureFil Technology to minimize adverse reactions.

The growing prevalence of zoonotic diseases and heightened focus on comprehensive pet care are also pushing pharmaceutical companies toward developing recombinant and precision-targeted vaccines. Strengthened regulatory support and rising investments in veterinary R&D further expand opportunities for innovation in this sector.

Market Trends

A leading trend in the canine vaccines industry is the shift toward easy-to-administer vaccine formats, particularly intranasal and oral vaccines. These modes reduce stress on pets, minimize handling requirements, and activate rapid mucosal immune responses. In March 2025, Zoetis introduced the Vanguard B Intranasal vaccine, a 0.5 mL formulation offering protection against Bordetella bronchiseptica, showcasing the market's movement toward user-friendly vaccine delivery.

Regional Insights

North America - Market Leader

North America held the largest share of the global market in 2024, valued at USD 0.84 billion, representing 44.91% of global revenue. The region benefits from high pet adoption, advanced veterinary care, and significant presence of leading manufacturers such as Zoetis, Merck & Co., and Elanco. The U.S. remains the largest contributor due to strong guidelines for canine vaccination and increased spending on companion animal healthcare.

Europe

Europe is expected to exhibit considerable growth, supported by increasing awareness of canine disease risks and higher pet ownership. The U.K., with 28% of adults owning dogs, is a key contributor to regional expansion.

Asia Pacific

Asia Pacific is forecast to grow at the fastest rate through 2032. The rise in urban pet ownership, new product introductions, and partnerships-such as Bioveta's collaboration with Vetina Healthcare in India-support rapid market development.

Latin America & Middle East & Africa

These regions show moderate but steady growth, strongly supported by government-led rabies vaccination programs and rising awareness of companion animal health.

Competitive Landscape

The market is semi-fragmented, with major players including Zoetis Services LLC, Merck & Co., Inc., Elanco, Virbac, Ceva, Bioveta, Indian Immunologicals Ltd., HIPRA, and Brilliant Bio Pharma. These companies are expanding through new product launches, multi-disease vaccine development, strategic partnerships, and investment in advanced manufacturing capabilities.

Segmentation By Technology

  • Inactivated
  • Live Attenuated
  • Recombinant
  • Others

By Disease Type

  • Canine Influenza
  • Lyme Disease
  • Rabies
  • Leptospirosis
  • Others

By Route of Administration

  • Oral
  • Parenteral
  • Intranasal

By Distribution Channel

  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies & Drug Stores
  • Others

By Region

  • North America (By Technology, By Disease Type, By Route of Administration, By Distribution Channel, By Country/ Sub-Region)
    • U.S.
    • Canada
  • Europe (By Technology, By Disease Type, By Route of Administration, By Distribution Channel, By Country/ Sub-Region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Technology, By Disease Type, By Route of Administration, By Distribution Channel, By Country/ Sub-Region)
    • Japan
    • China
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Technology, By Disease Type, By Route of Administration, By Distribution Channel, By Country/ Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Technology, By Disease Type, By Route of Administration, By Distribution Channel, By Country/ Sub-Region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Overview of Canine Diseases by Key Countries, By Key Countries/ Region, 2024
  • 4.2. Regulatory Scenario by Key Countries/ Region, 2024
  • 4.3. Overview of Vaccination for Canine Diseases
  • 4.4. New Technology Launches, By Key Players
  • 4.5. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)

5. Global Canine Vaccines Market Analysis, Insights and Forecast, 2019-2032

  • 5.1. Market Analysis, Insights and Forecast - By Technology
    • 5.1.1. Inactivated
    • 5.1.2. Live Attenuated
    • 5.1.3. Recombinant
    • 5.1.4. Others
  • 5.2. Market Analysis, Insights and Forecast - By Disease Type
    • 5.2.1. Canine Influenza
    • 5.2.2. Lyme Disease
    • 5.2.3. Rabies
    • 5.2.4. Leptospirosis
    • 5.2.5. Others
  • 5.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 5.3.1. Oral
    • 5.3.2. Parenteral
    • 5.3.3. Intranasal
  • 5.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 5.4.1. Veterinary Hospitals
    • 5.4.2. Veterinary Clinics
    • 5.4.3. Pharmacies & Drug Stores
    • 5.4.4. Others
  • 5.5. Market Analysis, Insights and Forecast - Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Canine Vaccines Market Analysis, Insights and Forecast, 2019-2032

  • 6.1. Market Analysis, Insights and Forecast - By Technology
    • 6.1.1. Inactivated
    • 6.1.2. Live Attenuated
    • 6.1.3. Recombinant
    • 6.1.4. Others
  • 6.2. Market Analysis, Insights and Forecast - By Disease Type
    • 6.2.1. Canine Influenza
    • 6.2.2. Lyme Disease
    • 6.2.3. Rabies
    • 6.2.4. Leptospirosis
    • 6.2.5. Others
  • 6.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 6.3.1. Oral
    • 6.3.2. Parenteral
    • 6.3.3. Intranasal
  • 6.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 6.4.1. Veterinary Hospitals
    • 6.4.2. Veterinary Clinics
    • 6.4.3. Pharmacies & Drug Stores
    • 6.4.4. Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Canine Vaccines Market Analysis, Insights and Forecast, 2019-2032

  • 7.1. Market Analysis, Insights and Forecast - By Technology
    • 7.1.1. Inactivated
    • 7.1.2. Live Attenuated
    • 7.1.3. Recombinant
    • 7.1.4. Others
  • 7.2. Market Analysis, Insights and Forecast - By Disease Type
    • 7.2.1. Canine Influenza
    • 7.2.2. Lyme Disease
    • 7.2.3. Rabies
    • 7.2.4. Leptospirosis
    • 7.2.5. Others
  • 7.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 7.3.1. Oral
    • 7.3.2. Parenteral
    • 7.3.3. Intranasal
  • 7.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 7.4.1. Veterinary Hospitals
    • 7.4.2. Veterinary Clinics
    • 7.4.3. Pharmacies & Drug Stores
    • 7.4.4. Others
  • 7.5. Market Analysis, Insights and Forecast - By Technology
    • 7.5.1. Inactivated
    • 7.5.2. Live Attenuated
    • 7.5.3. Recombinant
    • 7.5.4. Others
  • 7.6. Market Analysis, Insights and Forecast - By Disease Type
    • 7.6.1. Canine Influenza
    • 7.6.2. Lyme Disease
    • 7.6.3. Rabies
    • 7.6.4. Leptospirosis
    • 7.6.5. Others
  • 7.7. Market Analysis, Insights and Forecast - By Route of Administration
    • 7.7.1. Oral
    • 7.7.2. Parenteral
    • 7.7.3. Intranasal
  • 7.8. Market Analysis, Insights and Forecast - By Distribution Channel
    • 7.8.1. Veterinary Hospitals
    • 7.8.2. Veterinary Clinics
    • 7.8.3. Pharmacies & Drug Stores
    • 7.8.4. Others
  • 7.9. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.9.1. Germany
    • 7.9.2. U.K.
    • 7.9.3. France
    • 7.9.4. Italy
    • 7.9.5. Spain
    • 7.9.6. Scandinavia
    • 7.9.7. Rest of Europe

8. Asia Pacific Canine Vaccines Market Analysis, Insights and Forecast, 2019-2032

  • 8.1. Market Analysis, Insights and Forecast - By Technology
    • 8.1.1. Inactivated
    • 8.1.2. Live Attenuated
    • 8.1.3. Recombinant
    • 8.1.4. Others
  • 8.2. Market Analysis, Insights and Forecast - By Disease Type
    • 8.2.1. Canine Influenza
    • 8.2.2. Lyme Disease
    • 8.2.3. Rabies
    • 8.2.4. Leptospirosis
    • 8.2.5. Others
  • 8.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 8.3.1. Oral
    • 8.3.2. Parenteral
    • 8.3.3. Intranasal
  • 8.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 8.4.1. Veterinary Hospitals
    • 8.4.2. Veterinary Clinics
    • 8.4.3. Pharmacies & Drug Stores
    • 8.4.4. Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.5.1. China
    • 8.5.2. Japan
    • 8.5.3. India
    • 8.5.4. Australia
    • 8.5.5. Southeast Asia
    • 8.5.6. Rest of Asia Pacific

9. Latin America Canine Vaccines Market Analysis, Insights and Forecast, 2019-2032

  • 9.1. Market Analysis, Insights and Forecast - By Technology
    • 9.1.1. Inactivated
    • 9.1.2. Live Attenuated
    • 9.1.3. Recombinant
    • 9.1.4. Others
  • 9.2. Market Analysis, Insights and Forecast - By Disease Type
    • 9.2.1. Canine Influenza
    • 9.2.2. Lyme Disease
    • 9.2.3. Rabies
    • 9.2.4. Leptospirosis
    • 9.2.5. Others
  • 9.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 9.3.1. Oral
    • 9.3.2. Parenteral
    • 9.3.3. Intranasal
  • 9.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 9.4.1. Veterinary Hospitals
    • 9.4.2. Veterinary Clinics
    • 9.4.3. Pharmacies & Drug Stores
    • 9.4.4. Others
  • 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America

10. Middle East & Africa Canine Vaccines Market Analysis, Insights and Forecast, 2019-2032

  • 10.1. Market Analysis, Insights and Forecast - By Technology
    • 10.1.1. Inactivated
    • 10.1.2. Live Attenuated
    • 10.1.3. Recombinant
    • 10.1.4. Others
  • 10.2. Market Analysis, Insights and Forecast - By Disease Type
    • 10.2.1. Canine Influenza
    • 10.2.2. Lyme Disease
    • 10.2.3. Rabies
    • 10.2.4. Leptospirosis
    • 10.2.5. Others
  • 10.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 10.3.1. Oral
    • 10.3.2. Parenteral
    • 10.3.3. Intranasal
  • 10.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 10.4.1. Veterinary Hospitals
    • 10.4.2. Veterinary Clinics
    • 10.4.3. Pharmacies & Drug Stores
    • 10.4.4. Others
  • 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.5.1. GCC
    • 10.5.2. South Africa
    • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2024)
  • 11.2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability)
    • 11.2.1. Elanco
    • 11.2.2. Boehringer Ingelheim International GmbH
    • 11.2.3. Virbac
    • 11.2.4. Merck & Co., Inc.
    • 11.2.5. Zoetis Services LLC
    • 11.2.6. Ceva
    • 11.2.7. Bioveta, a.s.
    • 11.2.8. Indian Immunologicals Ltd.
    • 11.2.9. HIPRA
    • 11.2.10. Brilliant Bio Pharma (India)

List of Tables

  • Table 1: Global Canine Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019-2032
  • Table 2: Global Canine Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2019-2032
  • Table 3: Global Canine Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 4: Global Canine Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 5: Global Canine Vaccines Market Revenue (USD billion) Forecast, by Region, 2019-2032
  • Table 6: North America Canine Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019-2032
  • Table 7: North America Canine Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2019-2032
  • Table 8: North America Canine Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 9: North America Canine Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 10: North America Canine Vaccines Market Revenue (USD billion) Forecast, By Country, 2019-2032
  • Table 11: Europe Canine Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019-2032
  • Table 12: Europe Canine Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2019-2032
  • Table 13: Europe Canine Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 14: Europe Canine Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 15: Europe Canine Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 16: Asia Pacific Canine Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019-2032
  • Table 17: Asia Pacific Canine Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2019-2032
  • Table 18: Asia Pacific Canine Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 19: Asia Pacific Canine Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 20: Asia Pacific Canine Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 21: Latin America Canine Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019-2032
  • Table 22: Latin America Canine Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2019-2032
  • Table 23: Latin America Canine Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 24: Latin America Canine Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 25: Latin America Canine Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 26: Middle East & Africa Canine Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019-2032
  • Table 27: Middle East & Africa Canine Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2019-2032
  • Table 28: Middle East & Africa Canine Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 29: Middle East & Africa Canine Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 30: Middle East & Africa Canine Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

List of Figures

  • Figure 1: Global Canine Vaccines Market Revenue Breakdown (USD billion, %) by Region, 2024 & 2032
  • Figure 2: Global Canine Vaccines Market Value Share (%), by Technology, 2024 & 2032
  • Figure 3: Global Canine Vaccines Market Value Share (%), by Disease Type, 2024 & 2032
  • Figure 4: Global Canine Vaccines Market Value Share (%), by Route of Administration, 2024 & 2032
  • Figure 5: Global Canine Vaccines Market Value Share (%), by Distribution Channel, 2024 & 2032
  • Figure 6: Global Canine Vaccines Market Value Share (%), by Region, 2024 & 2032
  • Figure 7: North America Canine Vaccines Market Value (USD billion), by Technology, 2024 & 2032
  • Figure 8: North America Canine Vaccines Market Value Share (%), by Technology, 2024
  • Figure 9: North America Canine Vaccines Market Value (USD billion), by Disease Type, 2024 & 2032
  • Figure 10: North America Canine Vaccines Market Value Share (%), by Disease Type, 2024
  • Figure 11: North America Canine Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032
  • Figure 12: North America Canine Vaccines Market Value Share (%), by Route of Administration, 2024
  • Figure 13: North America Canine Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
  • Figure 14: North America Canine Vaccines Market Value Share (%), by Distribution Channel, 2024
  • Figure 15: North America Canine Vaccines Market Value (USD billion), By Country, 2024 & 2032
  • Figure 16: North America Canine Vaccines Market Value Share (%), By Country, 2024
  • Figure 17: Europe Canine Vaccines Market Value (USD billion), by Technology, 2024 & 2032
  • Figure 18: Europe Canine Vaccines Market Value Share (%), by Technology, 2024
  • Figure 19: Europe Canine Vaccines Market Value (USD billion), by Disease Type, 2024 & 2032
  • Figure 20: Europe Canine Vaccines Market Value Share (%), by Disease Type, 2024
  • Figure 21: Europe Canine Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032
  • Figure 22: Europe Canine Vaccines Market Value Share (%), by Route of Administration, 2024
  • Figure 23: Europe Canine Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
  • Figure 24: Europe Canine Vaccines Market Value Share (%), by Distribution Channel, 2024
  • Figure 25: Europe Canine Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 26: Europe Canine Vaccines Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 27: Asia Pacific Canine Vaccines Market Value (USD billion), by Technology, 2024 & 2032
  • Figure 28: Asia Pacific Canine Vaccines Market Value Share (%), by Technology, 2024
  • Figure 29: Asia Pacific Canine Vaccines Market Value (USD billion), by Disease Type, 2024 & 2032
  • Figure 30: Asia Pacific Canine Vaccines Market Value Share (%), by Disease Type, 2024
  • Figure 31: Asia Pacific Canine Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032
  • Figure 32: Asia Pacific Canine Vaccines Market Value Share (%), by Route of Administration, 2024
  • Figure 33: Asia Pacific Canine Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
  • Figure 34: Asia Pacific Canine Vaccines Market Value Share (%), by Distribution Channel, 2024
  • Figure 35: Asia Pacific Canine Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 36: Asia Pacific Canine Vaccines Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 37: Latin America Canine Vaccines Market Value (USD billion), by Technology, 2024 & 2032
  • Figure 38: Latin America Canine Vaccines Market Value Share (%), by Technology, 2024
  • Figure 39: Latin America Canine Vaccines Market Value (USD billion), by Disease Type, 2024 & 2032
  • Figure 40: Latin America Canine Vaccines Market Value Share (%), by Disease Type, 2024
  • Figure 41: Latin America Canine Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032
  • Figure 42: Latin America Canine Vaccines Market Value Share (%), by Route of Administration, 2024
  • Figure 43: Latin America Canine Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
  • Figure 44: Latin America Canine Vaccines Market Value Share (%), by Distribution Channel, 2024
  • Figure 45: Latin America Canine Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 46: Latin America Canine Vaccines Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 47: Middle East & Africa Canine Vaccines Market Value (USD billion), by Technology, 2024 & 2032
  • Figure 48: Middle East & Africa Canine Vaccines Market Value Share (%), by Technology, 2024
  • Figure 49: Middle East & Africa Canine Vaccines Market Value (USD billion), by Disease Type, 2024 & 2032
  • Figure 50: Middle East & Africa Canine Vaccines Market Value Share (%), by Disease Type, 2024
  • Figure 51: Middle East & Africa Canine Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032
  • Figure 52: Middle East & Africa Canine Vaccines Market Value Share (%), by Route of Administration, 2024
  • Figure 53: Middle East & Africa Canine Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
  • Figure 54: Middle East & Africa Canine Vaccines Market Value Share (%), by Distribution Channel, 2024
  • Figure 55: Middle East & Africa Canine Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 56: Middle East & Africa Canine Vaccines Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 57: Global Canine Vaccines Market Share (%), By Company, 2024